Summary & Overview
CPT 94664: Demonstration and Evaluation of Inhalation Device Use
CPT code 94664 covers the demonstration and evaluation of patient use of inhalation devices, including aerosol generators, nebulizers, metered dose inhalers, and IPPB devices. This procedure is a cornerstone in pulmonary care, helping patients effectively manage respiratory conditions such as asthma and chronic obstructive pulmonary disease. The code is widely recognized and reimbursed by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
This publication provides a comprehensive overview of 94664, detailing its clinical significance, typical site of service, and payer coverage. Readers will gain insights into current policy updates, utilization benchmarks, and the clinical context for this procedure. The analysis also highlights relevant modifiers and associated taxonomies, offering a clear understanding of how 94664 fits within broader pulmonary diagnostic and therapeutic services. By focusing on national trends and payer policies, the article equips healthcare professionals and administrators with the information needed to navigate billing and compliance for this essential pulmonary service.
CPT Code Overview
CPT code 94664 is used for the demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler, or IPPB device. This service is classified under Pulmonary Diagnostic Testing and Therapies and is typically performed in an office setting (Place of Service 11). The procedure is essential for ensuring patients understand how to properly use inhalation devices, which are critical for the management of various respiratory conditions.
Clinical & Coding Specifications
Clinical Context
A patient with chronic respiratory conditions, such as chronic obstructive pulmonary disease or asthma, presents to the office for evaluation and management. During the visit, the provider demonstrates and evaluates the patient's use of an aerosol generator, nebulizer, metered dose inhaler, or IPPB device. This ensures the patient understands proper technique and device utilization, which is critical for effective medication delivery and symptom control. The workflow typically involves assessment of the patient's current technique, education on correct usage, and documentation of the demonstration and evaluation.
Coding Specifications
- Modifier
59: Distinct procedural service. Used when94664is billed together with94640in the same encounter to indicate that the procedures are separate and distinct.
| Modifier Code | Description |
|---|---|
59 | Distinct procedural service—for use when 94664 is billed together with 94640 in the same encounter to indicate separate procedures |
- Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207RP1001X | Pulmonary Disease Physician |
207RC0200X | Critical Care Medicine Physician |
207RI0008X | Interventional Pulmonology Physician |
Related Diagnoses
-
J44.1- Chronic obstructive pulmonary disease with (acute) exacerbation- Relevant for patients experiencing acute worsening of COPD symptoms, often requiring inhalation therapy and device education.
-
J45.909- Unspecified asthma, uncomplicated- Applies to patients with asthma who may need instruction on inhaler or nebulizer use for ongoing management.
-
J45.901- Unspecified asthma with (acute) exacerbation- Used when a patient has an acute asthma episode, necessitating proper inhalation technique for effective treatment.
-
J44.9- Chronic obstructive pulmonary disease, unspecified- Indicates COPD without specification, where inhalation devices are commonly used and require demonstration.
-
R06.02- Shortness of breath- Symptom code relevant for patients presenting with dyspnea, often leading to evaluation and education on inhalation device usage.
Related CPT Codes
94640- Nonpressurized inhalation treatment for acute airway obstruction
94640 is related to 94664 as both involve respiratory therapies. 94640 is used for administering inhalation treatments to relieve acute airway obstruction, while 94664 focuses on demonstration and evaluation of patient technique with inhalation devices. These codes are commonly used together in the same encounter, especially when a patient receives an inhalation treatment and also requires education or evaluation of their device usage. Modifier 59 is applied to distinguish these as separate procedures.
National Reimbursement Benchmarks
National mean rates for CPT code 94664 show that Medicare reimburses at $20.93, which is notably lower than the BUCA (average commercial) mean rate of $26.21. Commercial payers such as Aetna, Cigna, and UnitedHealth Group all have mean rates above $25, with Cigna reaching the highest at $28.99.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare has the tightest range at $3.00, indicating minimal variation in rates. Cigna exhibits the widest dispersion at $16.00, reflecting greater variability in commercial reimbursement. Other commercial payers, including UnitedHealth Group and Aetna, also show broader ranges compared to Medicare.
The table and chart below present a detailed breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.